Rs4862705 in the melatonin receptor 1A gene is associated with renal function decline in type 1 diabetes individuals.
antioxidant activity
diabetes-related complications
diabetic kidney disease
genetic polymorphism
melatonin receptors
type 1 diabetes mellitus
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2024
2024
Historique:
received:
31
10
2023
accepted:
21
02
2024
medline:
29
3
2024
pubmed:
29
3
2024
entrez:
29
3
2024
Statut:
epublish
Résumé
The pathogenesis of chronic diabetes complications has oxidative stress as one of the major elements, and single-nucleotide polymorphisms (SNPs) in genes belonging to antioxidant pathways modulate susceptibility to these complications. Considering that melatonin is a powerful antioxidant compound, our aim was to explore, in a longitudinal cohort study of type 1 diabetes (T1D) individuals, the association of microvascular complications and SNPs in the gene encoding melatonin receptor 1A ( Eight SNPs in The group of individuals with a renal function decline ≥ 5 mL min This is the first study showing an association between a variant in a gene belonging to the melatonin system and renal function decline in the diabetic setting.
Identifiants
pubmed: 38549765
doi: 10.3389/fendo.2024.1331012
pmc: PMC10972958
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1331012Informations de copyright
Copyright © 2024 Daher, Santos-Bezerra, Cavaleiro, Pelaes, Admoni, Perez, Machado, Amaral, Cipolla-Neto and Correa-Giannella.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.